Aurora kinase B inhibitor barasertib (AZD1152) inhibits glucose metabolism in gastric cancer cells.

He, Jian

Aurora kinase B inhibitor barasertib (AZD1152) inhibits glucose metabolism in gastric cancer cells. [electronic resource] - Anti-cancer drugs 01 2019 - 19-26 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

1473-5741

10.1097/CAD.0000000000000684 doi


Aurora Kinase B--antagonists & inhibitors
Case-Control Studies
Cell Line, Tumor
Dose-Response Relationship, Drug
Glucose--metabolism
Glucose Transporter Type 1--metabolism
Humans
Isoenzymes--metabolism
L-Lactate Dehydrogenase--metabolism
Organophosphates--pharmacology
Promoter Regions, Genetic
Protein Kinase Inhibitors--pharmacology
Proto-Oncogene Proteins c-myc--genetics
Quinazolines--pharmacology
Ribosomal Proteins--metabolism
Stomach Neoplasms--drug therapy